Literature DB >> 24770865

Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives.

Kristen Dilzell1, Kerry Kingham, Kelly Ormond, Uri Ladabaum.   

Abstract

Facilitating family communication about Lynch syndrome is a public health priority since following appropriate screening guidelines can decrease morbidity and mortality. The aims of this study were to (1) ascertain what educational materials individuals with Lynch syndrome provide to at-risk relatives, and (2) identify relationships between receiving educational materials and pursuing clinical follow-up. Seventy-four participants, recruited from the Stanford Cancer Institute and a support group, completed an online questionnaire; 50 were first to be diagnosed with a Lynch syndrome mutation in their family (probands) and 24 were first or second-degree relatives. Probands reported informing 88 % (184/209) of first-degree relatives and 64 % (161/252) of second-degree relatives of the mutation. Probands shared their genetic counseling note with 53 % of relatives; other resources, including family letters, personal notes, testing laboratory information, online resources, support group information, and genetics referrals, were given to 33 % or fewer relatives. Probands reported that female relatives (p = 0.028) and first-degree relatives (p ≤ 0.001) were more likely to be given materials. Relatives who received an educational material were more likely to follow up with a clinician (74 vs 22 %, p ≤0.001) and attend a genetic counseling appointment (43 vs 16 %, p ≤ 0.001). First-degree relatives who received an educational material were more likely to have undergone genetic testing (51 vs 19 %, p = 0.012) and cancer screening (69 vs 29 %, p = 0.001). Facilitating information transmission in families with Lynch syndrome using educational materials may play a role in informed clinical decision-making and cascade screening of at-risk relatives.

Entities:  

Mesh:

Year:  2014        PMID: 24770865     DOI: 10.1007/s10689-014-9720-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  23 in total

Review 1.  Communicating genetic risk information within families: a review.

Authors:  Mel Wiseman; Caroline Dancyger; Susan Michie
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

Review 3.  Communicating genetic information in families--a review of guidelines and position papers.

Authors:  Laura E Forrest; Martin B Delatycki; Loane Skene; MaryAnne Aitken
Journal:  Eur J Hum Genet       Date:  2007-03-28       Impact factor: 4.246

4.  Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.

Authors:  Elena M Stoffel; Beth Ford; Rowena C Mercado; Darashana Punglia; Wendy Kohlmann; Peggy Conrad; Amie Blanco; Kristen M Shannon; Mark Powell; Stephen B Gruber; Jonathan Terdiman; Daniel C Chung; Sapna Syngal
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02-07       Impact factor: 11.382

5.  Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study.

Authors:  Ilse Mesters; Marlein Ausems; Sophie Eichhorn; Hans Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 6.  What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research.

Authors:  Kim Chivers Seymour; Julia Addington-Hall; Anneke M Lucassen; Claire L Foster
Journal:  J Genet Couns       Date:  2010-04-09       Impact factor: 2.537

7.  The "duty to warn" a patient's family members about hereditary disease risks.

Authors:  Kenneth Offit; Elizabeth Groeger; Sam Turner; Eve A Wadsworth; Mary A Weiser
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

8.  Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.

Authors:  Claire E Wakefield; Bettina Meiser; Judi Homewood; Robyn Ward; Sheridan O'Donnell; Judy Kirk
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

Review 9.  Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.

Authors:  Ravi N Sharaf; Parvathi Myer; Christopher D Stave; Lisa C Diamond; Uri Ladabaum
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382

Review 10.  Guidelines for disclosing genetic information to family members: from development to use.

Authors:  Béatrice Godard; Thierry Hurlimann; Martin Letendre; Nathalie Egalité
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

View more
  13 in total

1.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

2.  Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group.

Authors:  Marina J Corines; Jada G Hamilton; Emily Glogowski; Chris A Anrig; Rachael Goldberg; Kate Niehaus; Erin Salo-Mullen; Megan Harlan; Margaret R Sheehan; Magan Trottier; Asad Ahsraf; Christina Tran; Lauren Jacobs; Rohini Rau-Murthy; Anne G Lincoln; Mark E Robson; Jose G Guillem; Arnold J Markowitz; Kenneth Offit; Zsofia K Stadler
Journal:  J Genet Couns       Date:  2016-10-12       Impact factor: 2.537

Review 3.  Disparities in gynecologic cancer genetics evaluation.

Authors:  Emily M Hinchcliff; Erica M Bednar; Karen H Lu; J Alejandro Rauh-Hain
Journal:  Gynecol Oncol       Date:  2019-01-31       Impact factor: 5.482

4.  Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis.

Authors:  Jenna Petersen; Cathryn Koptiuch; Yelena P Wu; Ryan Mooney; Ashley Elrick; Kathryn Szczotka; Megan Keener; Lisa Pappas; Priyanka Kanth; Andrew Soisson; Wendy Kohlmann; Kimberly A Kaphingst
Journal:  Patient Educ Couns       Date:  2018-07-26

Review 5.  Barriers and facilitators for cascade testing in genetic conditions: a systematic review.

Authors:  Swetha Srinivasan; Nae Yeon Won; W David Dotson; Sarah T Wright; Megan C Roberts
Journal:  Eur J Hum Genet       Date:  2020-09-18       Impact factor: 4.246

6.  Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.

Authors:  Swetha Srinivasan; Heather Hampel; Jennifer Leeman; Amit Patel; Alanna Kulchak Rahm; Daniel S Reuland; Megan C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

7.  The Use of Social Media to Recruit Participants With Rare Conditions: Lynch Syndrome as an Example.

Authors:  Allison M Burton-Chase; Wendy M Parker; Kelsey Hennig; Faith Sisson; Linda L Bruzzone
Journal:  JMIR Res Protoc       Date:  2017-01-23

Review 8.  Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.

Authors:  Deborah Cragun; Anita Y Kinney; Tuya Pal
Journal:  Expert Rev Mol Diagn       Date:  2016-12-13       Impact factor: 5.225

9.  Development of a Secure Website to Facilitate Information Sharing in Families at High Risk of Bowel Cancer-The Familyweb Study.

Authors:  Selina Goodman; Heather Skirton; Leigh Jackson; Ray B Jones
Journal:  Cancers (Basel)       Date:  2021-05-16       Impact factor: 6.639

10.  Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing.

Authors:  Cameron B Haas; Aaron Scrol; Chethan Jujjavarapu; Gail P Jarvik; Nora B Henrikson
Journal:  Health Policy Technol       Date:  2021-04-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.